J. Miro

发表

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

G. M. Ortiz, D. Nixon, S. Bonhoeffer, 2001, AIDS.

A New Multidisciplinary Home Care Telemedicine System to Monitor Stable Chronic Human Immunodeficiency Virus-Infected Patients: A Randomized Study

E. Gómez, Felipe García, J. Miro, 2011, PloS one.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Gemma Navarro, Elena Ferrer, Anna Esteve, 2008, Journal of acquired immune deficiency syndromes.

Current Epidemiology and Outcome of Infective Endocarditis

J. Miro, J. Bermejo, H. Rodríguez-Abella, 2015, Medicine.

Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome.

Vance G Fowler, Lluis Mont, J. Miro, 2003, Chest.

Executive summary of the diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

Á. Soriano, J. Miro, E. Bouza, 2015, Enfermedades infecciosas y microbiologia clinica.

Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC).

Á. Soriano, J. Miro, E. Bouza, 2015, Enfermedades infecciosas y microbiologia clinica.

Prevention of infective endocarditis: between progress in scientific knowledge and the lack of randomized trials.

J. Miro, C. Falces, 2012, Revista espanola de cardiologia.

[Infections associated with prosthetic heart valves, vascular prostheses, and cardiac pacemakers and defibrillators].

J. Miro, B. Almirante, 2008, Enfermedades infecciosas y microbiologia clinica.

Relationship between Vancomycin MIC and Virulence Gene Expression in Clonal Complexes of Methicillin-Susceptible Staphylococcus aureus Strains Isolated from Left-Sided Endocarditis

J. Miro, B. Sharma-Kuinkel, V. Fowler, 2020, Antimicrobial Agents and Chemotherapy.

Intensification of a raltegravir-based regimen with maraviroc in early HIV-1 infection

B. Clotet, J. Martinez-Picado, J. Miro, 2014, AIDS.

Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection

J. Miro, J. Gatell, J. Blanco, 2017, The Journal of antimicrobial chemotherapy.

Characteristics and Outcome of Streptococcus pneumoniae Endocarditis in the XXI Century

J. Miro, P. García-Pavía, E. Bouza, 2015, Medicine.

Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque.

P. D. de Bakker, J. Fellay, A. Telenti, 2011, The Journal of clinical investigation.

Progressive multifocal leukoencephalopathy in HIV-1 infection.

J. Miro, R. Price, P. Cinque, 2009, The Lancet. Infectious diseases.

Polymorphisms in the interleukin-4 receptor α chain gene influence susceptibility to HIV-1 infection and its progression to AIDS

Felipe García, M. Plana, Á. Soriano, 2005, Immunogenetics.

Infective endocarditis in intravenous drug abusers and HIV-1 infected patients.

J. Miro, C. Mestres, A. del Río, 2002, Infectious disease clinics of North America.

Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.

Jessica G. Young, M. Hernán, J. Sterne, 2015, The lancet. HIV.

Editorial comment Allograft aortic root replacement in complex prosthetic valve endocarditis

J. Miro, C. Mestres, 2007 .

Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1–Infected Patients Starting Efavirenz, Lopinavir–Ritonavir, or Atazanavir–Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial)

D. Podzamczer, B. Clotet, M. Plana, 2015, Journal of acquired immune deficiency syndromes.

Community-acquired lung respiratory infections in HIV-infected patients: microbial aetiology and outcome

J. Miro, A. Torres, A. Moreno, 2014, European Respiratory Journal.

Infective Endocarditis in Patients on Chronic Hemodialysis.

J. Miro, V. Fowler, S. Lerakis, 2021, Journal of the American College of Cardiology.

Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs.

M. Hannan, J. Miro, D. Murdoch, 2021, Journal of the American College of Cardiology.

A Contemporary Picture of Enterococcal Endocarditis.

J. Miro, P. Muñoz, J. Pericàs, 2020, Journal of the American College of Cardiology.

The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century

J. Miro, A. Moreno, J. Pericàs, 2017, Current Infectious Disease Reports.

Prognostic factors of infective endocarditis in patients on hemodialysis: A case series from a National Multicenter Registry.

J. Miro, P. García-Pavía, J. De La Torre, 2017, International journal of cardiology.

Role of Echocardiogram in Decision Making for Surgery in Endocarditis

J. Miro, G. Fita, C. Mestres, 2010, Current infectious disease reports.

Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK

P. Easterbrook, J. Miro, D. Schellenberg, 2013, AIDS.

Predictors of Immune Reconstitution Inflammatory Syndrome–Associated With Kaposi Sarcoma in Mozambique: A Prospective Study

C. Menéndez, J. Miro, P. Alonso, 2009, Journal of acquired immune deficiency syndromes.

[Mortality and morbidity in HIV-infected patients undergoing coronary artery bypass surgery: a case control study].

J. Miro, M. Josa, J. Pomar, 2006, Revista espanola de cardiologia.

High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial.

John L. Johnson, K. Dooley, R. Chaisson, 2020, Contemporary clinical trials.

International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass.

M. Hannan, J. Miro, J. Lundgren, 2019, The Journal of hospital infection.

Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy

J. Miro, F. Diekmann, F. Cofán, 2018, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

Disseminated infection with cutaneous involvement caused by Mycobacterium malmoense in an immunocompromised patient.

J. Miro, M. Alsina-Gibert, Javier Fernández, 2013, Journal of the American Academy of Dermatology.

Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis

J. Miro, C. Arias, A. Bayer, 2017, Antimicrobial Agents and Chemotherapy.

Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality.

C. Tural, J. Miro, S. Moreno, 2009, Current HIV research.

A Simplification Trial Switching From Nucleoside Reverse Transcriptase Inhibitors to Once-Daily Fixed-Dose Abacavir/Lamivudine or Tenofovir/Emtricitabine in HIV-1-Infected Patients With Virological Suppression

D. Podzamczer, B. Clotet, J. Miro, 2009, Journal of acquired immune deficiency syndromes.

Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results.

J. Miro, J. Pomar, C. Mestres, 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Influence of treatment with zidovudine (ZDV) on the long-term survival of AIDS patients.

J. Miro, J. Gatell, J. Mallolas, 1992, Journal of acquired immune deficiency syndromes.

Regional differences in the management and outcome of kidney transplantation in patients with human immunodeficiency virus infection: A 3‐year retrospective cohort study

J. Miro, F. Diekmann, F. Oppenheimer, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Epidemiological and clinical characteristics of Streptococcus tigurinus endocarditis

J. Miro, J. De La Torre, P. Muñoz, 2019, BMC Infectious Diseases.

Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe.

A. Mocroft, O. Kirk, N. Chentsova, 2014, The Journal of infection.

Infective endocarditis and multidisciplinary work: a call for action in Asia

J. Miro, C. Mestres, E. Quintana, 2017, Asian cardiovascular & thoracic annals.

Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia.

J. Miro, J. Gatell, J. Mallolas, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Management of Dyslipidaemia in HIV-Infected Patients Receiving Antiretroviral Therapy

J. Miro, J. Gatell, E. Martinez, 2004, Antiviral therapy.

Human immunodeficiency virus–infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study

J. Miro, A. Forner, I. Bilbao, 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Management of end-stage liver disease in HIV-infected patients

J. Miro, M. Laguno, A. Rimola, 2007, Current opinion in HIV and AIDS.

Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)?

J. Miro, M. Laguno, A. Rimola, 2006, Journal of hepatology.

Liver Transplantation in HIV-Infected Patients: Update in 2006

J. Miro, M. Laguno, A. Rimola, 2006 .

Relationship Between Enterococcus faecalis Infective Endocarditis and Colorectal Neoplasm: Preliminary Results From a Cohort of 154 Patients.

J. Miro, A. Castells, A. Moreno, 2017, Revista espanola de cardiologia.

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

C. Leen, A. Mocroft, O. Kirk, 2017, HIV medicine.

Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.

Richard D Moore, J. Robins, M. Hernán, 2017, The lancet. HIV.

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

M. Hernán, D. Podzamczer, A. Winston, 2014, Neurology.

Infections in solid organ transplant HIV-infected patients.

J. Miro, N. Mueller, P. Grossi, 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial.

D. Podzamczer, M. Plana, A. Cruceta, 2010, AIDS research and human retroviruses.

HIV-1 infected patients older than 50 years. PISCIS cohort study.

D. Podzamczer, B. Clotet, C. Tural, 2008, The Journal of infection.

A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients.

J. Miro, J. Gatell, J. Mallolas, 2007, Revista clinica espanola.

Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1).

J. Miro, J. Pomar, C. Mestres, 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update.

J. Miro, N. Terrault, P. Stock, 2015, Journal of hepatology.

Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.

J. Miro, M. Laguno, J. Montero, 2015, Journal of hepatology.

Tuberculosis Recurrence after Completion Treatment in a European City: Reinfection or Relapse?

J. Miro, M. Casals, A. Orcau, 2013, PloS one.

Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factors influencing prognosis.

J. Miro, J. Gatell, J. Miguel, 1988, Reviews of infectious diseases.

Pulmonary alveolar microlithiasis with an unusual radiological pattern.

J. Miro, A. Moreno, A. Coca, 1982, British journal of diseases of the chest.

Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition

Q. Bassat, S. de Sanjosé, J. Miro, 2021, Clinical Microbiology and Infection.

A prospective study of the risk of tuberculosis among HIV‐infected patients

D. Podzamczer, J. Miro, J. Gatell, 1993, AIDS.

Patients presenting with AIDS in the HAART era: a collaborative cohort analysis

C. Sabin, J. Miro, M. Johnson, 2008, AIDS.

Tuberculosis-HIV Co-Infection: Progress and Challenges After Two Decades of Global Antiretroviral Treatment Roll-Out.

A. Garcia-Basteiro, J. Miro, K. Naidoo, 2020, Archivos de bronconeumologia.

Tuberculosis-HIV Co-Infection: Progress and Challenges After Two Decades of Global Antiretroviral Treatment Roll-Out.

A. Garcia-Basteiro, J. Miro, K. Naidoo, 2020, Archivos de bronconeumologia.

Characteristics of tuberculosis in HIV-infected patients: a case-control study.

J. Miro, J. Gatell, J. Mallolas, 1988, AIDS.

Progressive Multifocal Leukoencephalopathy Complicating HIV-1 Infection

J. Miro, P. Cinque, I. Koralnik, 2010 .

Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

J. Miro, J. Gatell, A. Moreno, 2009, Antimicrobial Agents and Chemotherapy.

Management of persistent tricuspid endocarditis with transplantation of cryopreserved mitral homografts.

J. Miro, J. Pomar, C. Mestres, 1994, The Journal of thoracic and cardiovascular surgery.

Patterns of resistance of Mycobacterium tuberculosis in Spanish patients infected with human immunodeficiency virus type 1 (HIV-1).

J. Miro, J. Gatell, J. Mallolas, 1995, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

An Update on Heart Transplantation in Human Immunodeficiency Virus–Infected Patients

J. Miro, J. Gatell, G. Guaraldi, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Infective endocarditis in patients with cancer: a consequence of invasive procedures or a harbinger of neoplasm?

J. Miro, P. Muñoz, A. de Alarcón, 2017, Medicine.

Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.

M. Lejeune, Felipe García, M. Plana, 2002, The Journal of infectious diseases.

HACEK infective endocarditis: Epidemiology, clinical features, and outcome: A case-control study.

J. Miro, D. Fuster, A. Moreno, 2018, International Journal of Infectious Diseases.

[Liver transplantation in patients with HIV infection].

J. Miro, A. Rimola, J. M. Miró, 2010, Gastroenterologia y hepatologia.

Failure of Cetirizine to Prevent Nevirapine-Associated Rash: A Double-Blind Placebo-Controlled Trial for the GESIDA 26/01 Study

J. Miro, J. Blanco, E. Ribera, 2004, Journal of acquired immune deficiency syndromes.

Organization and Functioning of a Multidisciplinary Team for the Diagnosis and Treatment of Infective Endocarditis: A 30-year Perspective (1985-2014).

J. Miro, J. Miró, C. Mestres, 2015, Revista espanola de cardiologia.

Viral load in asymptomatic patients with CD4+ lymphocyte counts above 500 × 106/l

Á. Soriano, C. Vidal, T. Pumarola, 1997, AIDS.

DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci

J. Miro, P. Muñoz, C. Herrero, 2019, Annals of Clinical Microbiology and Antimicrobials.

High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis

J. Miro, A. Moreno, F. Marco, 2012, Antimicrobial Agents and Chemotherapy.

Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.

J. Miro, A. Orcau, J. Caylà, 2017, The Lancet. Respiratory medicine.

Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon Î3 release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial

J. Miro, A. Orcau, J. Caylà, 2017 .

Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection.

Felipe García, M. Plana, A. Cruceta, 2005, The Journal of infectious diseases.

Twenty-year experience with cryopreserved arterial allografts for vascular infections†

J. Miro, D. Fuster, C. Mestres, 2018, European Journal of Cardio-Thoracic Surgery.

Infective endocarditis: an ongoing global challenge.

J. Miro, J. Ambrosioni, 2019, European heart journal.

2015 ESC Guidelines for the management of infective endocarditis.

J. Zamorano, J. Miro, B. Mulder, 2016, Revista española de cardiología.

Immune Restoration in HIV-Positive, Antiretroviral-Naive Patients after 1 Year of Zidovudine/Lamivudine plus Nelfinavir or Nevirapine

D. Podzamczer, Felipe García, M. Plana, 2004, Antiviral therapy.

Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.

M. Lejeune, Felipe García, M. Plana, 2002 .

Influence of vegetation size on the clinical presentation and outcome of lead-associated endocarditis: results from the MEDIC registry.

J. Miro, C. Tseng, L. Baddour, 2014, JACC. Cardiovascular imaging.

Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study

Felipe García, J. Miro, J. Mallolas, 2020, AIDS.

New Antivirals and Immune Therapies for COVID-19 Infection

R. Paredes, J. Miro, A. Torres, 2022, Archivos de Bronconeumología.

Burden of serious fungal infections in Spain.

J. Miro, D. Denning, A. Solé, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients

J. Miro, E. Poveda, V. Soriano, 2011, AIDS.

Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.

B. Clotet, J. Martinez-Picado, C. Brander, 2011, Vaccine.

Twice-Weekly Maintenance Therapy with Sulfadiazine-Pyrimethamine To Prevent Recurrent Toxoplasmic Encephalitis in Patients with AIDS

D. Podzamczer, J. Miro, J. Gatell, 1995, Annals of Internal Medicine.

Central nervous system toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy.

J. Miro, J. Gatell, J. Mercader, 1990, AIDS.

SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV

J. Miro, J. Casabona, A. Imaz, 2022, Microorganisms.

Short communication: reversible mitochondrial respiratory chain impairment during symptomatic hyperlactatemia associated with antiretroviral therapy.

Ò. Miró, J. Miro, J. Gatell, 2003, AIDS research and human retroviruses.

The continuum of HIV care in Catalonia

C. Tural, J. Miro, Gemma Navarro, 2015, AIDS care.

Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.

E. Negredo, J. Miro, J. Gatell, 2019, Enfermedades infecciosas y microbiologia clinica.

Valve surgery in active infective endocarditis: a simple score to predict in-hospital prognosis.

J. Miro, M. Martínez‐Sellés, E. Bouza, 2014, International journal of cardiology.

Infective endocarditis in patients with an implanted transcatheter aortic valve: Clinical characteristics and outcome of a new entity.

J. Miro, E. Sacanella, M. Sabaté, 2015, The Journal of infection.

The surgical treatment of infective endocarditis: An overview

J. Miro, C. Mestres, Hospital Clínico of Barcelona Infective Endocarditis Study Group, 2006 .

Analysis of Prognostic Factors in 274 Consecutive Episodes of Pseudomonas aeruginosa Bacteremia1

J. Miro, J. Gatell, J. Mallolas, 1991 .

Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia.

J. Miro, J. Gatell, J. Mallolas, 1991, Antibiotics and chemotherapy.

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

J. Miro, V. Fowler, W. O'Riordan, 2014, BMC Infectious Diseases.

Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy

J. Miro, Melissa D. Johnson, P. Tornos, 2015, Antimicrobial Agents and Chemotherapy.

Epidemiological changes of acute/recent human immunodeficiency virus type 1 infection in Barcelona, Spain (1997-2015): a prospective cohort study.

S. Yerly, M. Plana, J. Miro, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Humoral and Cellular Immune Responses After a 3-dose Course of mRNA-1273 COVID-19 Vaccine in Kidney Transplant Recipients: A Prospective Cohort Study

M. Juan, J. Miro, J. Rovira, 2022, Transplantation direct.

Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations

C. Tural, J. Miro, V. Soriano, 2004, Journal of viral hepatitis.

Antibiotic prophylaxis in non-cardiac thoracic surgery: cefazolin versus placebo.

J. Gimferrer, J. Miro, J. Gatell, 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens

J. Miro, A. Bayer, A. Moreno, 2019, Antimicrobial Agents and Chemotherapy.

The association between vegetation size and surgical treatment on 6-month mortality in left-sided infective endocarditis.

M. Hannan, J. Miro, C. Tribouilloy, 2018, European heart journal.

Risk factors of pericardial effusion in native valve infective endocarditis and its influence on outcome: A multicenter prospective cohort study.

J. Miro, A. Regueiro, M. Martínez‐Sellés, 2018, International journal of cardiology.

Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.

K. Anstrom, J. Miro, F. Vandenesch, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Infective endocarditis in intravenous drug abusers

J. Miro, A. Moreno, C. Mestres, 2003, Current infectious disease reports.

Q fever endocarditis in Spain. Clinical characteristics and outcome.

J. Miro, P. Tornos, P. Muñoz, 2011, Enfermedades infecciosas y microbiologia clinica.

Epidemiology of infections by HIV, Syphilis, Gonorrhea and Lymphogranuloma Venereum in Barcelona City: a population-based incidence study

J. Miro, J. Caylà, E. Ribera, 2015, BMC Public Health.

Haemophilus paraphrophilus endocarditis: case report and review.

J. Miro, B. Coll-Vinent, A. López-Soto, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Daptomycin: the role of high-dose and combination therapy for Gram-positive infections.

J. Miro, I. Gould, M. Rybak, 2013, International journal of antimicrobial agents.

Daptomycin Is Effective in Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus

J. Miro, J. Gatell, A. Moreno, 2008, Antimicrobial Agents and Chemotherapy.

HIV-1 Upregulates Intercellular Adhesion Molecule-1 Gene Expression in Lymphoid Tissue of Patients With Chronic HIV-1 Infection

Antonio Martínez, Felipe García, C. Gil, 2007, Journal of acquired immune deficiency syndromes.

Influence on survival of p24 antigen levels in patients with AIDS or advanced AIDS related complex treated with zidovudine

J. Miro, J. Gatell, L. Zamora, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Renal Dysfunction in the Setting of HIV/AIDS

J. Miro, J. Gatell, F. Oppenheimer, 2012, Current HIV/AIDS Reports.

Depressive Symptoms after Initiation of Interferon Therapy in Human Immunodeficiency Virus-Infected Patients with Chronic Hepatitis C

Felipe García, J. Miro, J. Gatell, 2004, Antiviral therapy.

The round table approach in infective endocarditis & cardiovascular implantable electronic devices infections: make your e-Team come true

J. Miro, P. Erba, R. Slart, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

Optimal Timing for Cardiac Surgery in Infective Endocarditis with Neurological Complications: A Narrative Review

J. Miro, X. Urra, E. Sandoval, 2022, Journal of clinical medicine.

COVID-19 in patients with HIV: clinical case series

Felipe García, Á. Soriano, J. Miro, 2020, The Lancet HIV.

Toxoplasmic encephalitis with normal CT scan and pathologic MRI.

J. Miro, F. Graus, H. Knobel, 1995, The American journal of medicine.

Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression

J. Miro, D. Cooper, J. Weber, 2014, AIDS.

Comparative eff ectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study

J. Sterne, C. Sabin, H. Furrer, 2015 .

Lessons for Tuberculosis and HIV Control from the Netherlands

J. Miro, J. Broekmans, Antonia Sambeat, 2015 .

Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection

P. Kaleebu, J. Miro, D. Cooper, 2016, Journal of acquired immune deficiency syndromes.

Enhanced Normalization of CD 4 / CD 8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection

P. Kaleebu, J. Miro, D. Cooper, 2022 .

Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome

Á. Soriano, J. Miro, J. Mallolas, 2020, International Journal of Infectious Diseases.

Metabolic and Immunological Effects of Antiretroviral Agents in Healthy Individuals Receiving Post-Exposure Prophylaxis

Felipe García, G. Mestre, M. Plana, 2001, Antiviral therapy.

2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Susanna Price, Gilbert Habib, Patrizio Lancellotti, 2015, European heart journal.

Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.

A. Cruceta, J. Miro, P. Muñoz, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial

J. Miro, J. Rodríguez-Baño, E. Calbo, 2015, BMJ Open.

Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature.

J. Miro, E. Martinez, E. Ribera, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Statement on the third dose of COVID-19 vaccines ( 16 / 09 / 2021 )

S. Sanjosé, Q. Bassat, J. Miro, 2021 .

Efficacy and Safety of Once-Daily Combination Therapy with Didanosine, Lamivudine and Nevirapine in Antiretroviral-Naive HIV-Infected Patients

J. Miro, J. Blanco, I. Ocaña, 2005, Antiviral therapy.

Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus.

J. Miro, L. Baddour, B. Hoen, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Urgent pneumococcal urinary antigen, importance in the diagnosis of acquired pneumonia in HIV-1 patients

Ò. Miró, J. Miro, A. Moreno, 2011, European journal of emergency medicine : official journal of the European Society for Emergency Medicine.

Immunoarchitecture of lymphoid tissue in HIV-infection during antiretroviral therapy correlates with viral persistence

E. Campo, Felipe García, J. Gatell, 2005, Modern Pathology.

High triglyceride levels as a predictor of mortality in AIDS patients.

J. Miro, L. Zamora, J. González-Clemente, 1993, AIDS.

Efficacy of Telavancin in the Treatment of Experimental Endocarditis Due to Glycopeptide-Intermediate Staphylococcus aureus

J. Miro, J. Gatell, A. Moreno, 2007, Antimicrobial Agents and Chemotherapy.

Pancreatic toxic effects associated with co-administration of didanosine and tenofovir in HIV-infected adults

Felipe García, J. Miro, J. Gatell, 2004, The Lancet.

LEGIONELLA PNEUMOPHILA ANTIGEN IN BRAIN

J. Miro, J. Gatell, M. Sasal, 1981, The Lancet.

Immunoblot Proﬁle as Predictor of Toxoplasmic Encephalitis in Patients Infected with Human Immunodeﬁciency Virus

J. Miro, B. Luft, P. Morlat, 2001 .

Sexual acquisition of HIV infection after solid organ transplantation: Late presentation and potentially fatal complications

J. Miro, M. Castel, H. Tedesco-Silva, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Septic arthritis of spinal apophyseal joint. Report of two cases and review of the literature.

J. Miro, P. Peris, J. Gratacós, 1992, Spine.

Septic arthritis in heroin addicts.

J. Miro, J. Gatell, J. Mallolas, 1991, Seminars in arthritis and rheumatism.

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0

S. McCormack, A. Mocroft, O. Kirk, 2018, HIV medicine.

Preserved central nervous system functioning after use of romidepsin as a latency-reversing agent in an HIV cure strategy

B. Clotet, C. Brander, J. Miro, 2021, AIDS.

Population-based assessment of SARS-CoV-2 infection among people living with HIV and the general population of Catalonia (March–December, 2020)

J. Miro, J. Casabona, R. Vivanco-Hidalgo, 2022, Enfermedades Infecciosas y Microbiología Clínica.

Costs and cost-effectiveness analysis of 2015 GESIDA/Spanish AIDS National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults.

D. Podzamczer, B. Clotet, J. Miro, 2017, Enfermedades infecciosas y microbiologia clinica.

National Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adults

D. Podzamczer, B. Clotet, J. Miro, 2016 .

[Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].

D. Podzamczer, B. Clotet, J. Miro, 2012, Enfermedades infecciosas y microbiologia clinica.

Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy.

J. Miro, J. Mallolas, M. García-Viejo, 2000, AIDS.

Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).

Felipe García, M. Plana, M. Arnedo, 2006, Enfermedades infecciosas y microbiologia clinica.

Systemic Candidiasis in Heroin Abusers Cutaneous Findings

J. Miro, C. Herrero, I. Bielsa, 1987, International journal of dermatology.

Candida albicans endocarditis possibly related to systemic candidiasis in a heroin addict

J. Miro, J. Bisbe, A. Moreno, 1987, European Journal of Clinical Microbiology.

Disseminated candidiasis in addicts who use brown heroin: report of 83 cases and review.

J. Miro, J. Gatell, J. Mallolas, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Costochondritis, endophthalmitis and pustulosis caused by Candida albicans in heroin addicts in Barcelona].

J. Gimferrer, J. Miro, J. Gatell, 1984, Medicina clínica (Ed. impresa).

Diagnostic value of serum antibody and antigen detection in heroin addicts with systemic candidiasis.

J. Miro, J. Mallolas, J. Bisbe, 1989, Reviews of infectious diseases.

Costochondral involvement in systemic candidiasis in heroin addicts: clinical, scintigraphic, and histologic features in 26 patients.

J. Rotés-Querol, J. Miro, J. Bisbe, 1988, Arthritis and rheumatism.

Aspergillosis in Drug Addicts

J. Miro, J. Bisbe, J. Trullas, 2009 .

Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.

A. d’Arminio Monforte, J. Miro, A. Lazzarin, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients.

J. Miro, Carlos A Mestres, Ana del Río, 2003, Cardiology clinics.

Multilocus Microsatellite Genotyping Array for Investigation of Genetic Epidemiology of Pneumocystis jirovecii

Steve M. Taylor, S. Meshnick, J. Miro, 2014, Journal of Clinical Microbiology.

TITLE : 1 A Multilocus Microsatellite Genotyping Array to Investigate the Genetic Epidemiology of Pneumocystis jirovecii 2

Steve M. Taylor, S. Meshnick, J. Miro, 2014 .

Prognostic factors influencing the outcome in pneumocystis carinii pneumonia in patients with AIDS.

R. Rodríguez-Roisín, J. Miro, J. Gatell, 1995, Thorax.

Pulmonary Infiltrates in HIV‐Infected Patients in the Highly Active Antiretroviral Therapy Era in Spain

T. Pumarola, J. Miro, J. Gatell, 2001, Journal of acquired immune deficiency syndromes.

Infections in solid organ transplantation in special situations: HIV-infection and immigration.

J. Miro, P. Martín-Dávila, F. Norman, 2012, Enfermedades infecciosas y microbiologia clinica.

Consensus document on the management of renal disease in HIV-infected patients.

E. Negredo, J. Miro, E. Martinez, 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Renal transplantation in HIV-infected patients: 2010 update.

J. Miro, F. Oppenheimer, J. Campistol, 2011, Kidney international.

Left-sided infective endocarditis in patients with liver cirrhosis.

C. Castillo, J. Miro, H. Rodríguez-Abella, 2015, The Journal of infection.

Systemic candidiasis in Spanish heroin addicts: a possible source of infection.

J. Miro, J. Gatell, J. Bisbe, 1987, The Journal of infectious diseases.

Pneumocystis pneumonia in the twenty-first century: HIV-infected versus HIV-uninfected patients

Felipe García, J. Miro, A. Torres, 2019, Expert review of anti-infective therapy.

Discontinuation of primary and secondary Toxoplasma gondii prophylaxis is safe in HIV-infected patients after immunological restoration with highly active antiretroviral therapy: results of an open, randomized, multicenter clinical trial.

D. Podzamczer, J. Miro, E. Martinez, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Design of a one-tube hemi-nested PCR for detection of Toxoplasma gondii and comparison of three DNA purification methods.

J. Miro, F. Derouin, M. T. Jiménez de Anta, 1999, Journal of medical microbiology.

Efficacy of octreotide in the management of chronic diarrhoea in AIDS.

B. Clotet, J. Romeu, G. Sirera, 1991, AIDS.

Failure of mebendazole treatment in Giardia lamblia infection.

J. Miro, A. Moreno, J. Gascón, 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

LB3. Daptomycin Plus Fosfomycin vs. Daptomycin Monotherapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Multicenter, Randomized, Clinical Trial

C. Tebé, J. Miro, S. Videla, 2018, Open Forum Infectious Diseases.

Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus

J. Miro, J. Gatell, A. Moreno, 2015, Antimicrobial Agents and Chemotherapy.

Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial

C. Tebé, Á. Soriano, J. Miro, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity

J. Miro, J. Grau, A. Moreno, 2008, Scandinavian journal of infectious diseases.

Brucellosis in patients infected with the human immunodeficiency virus

D. Podzamczer, J. Miro, A. Rivero, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

Switching from zidovudine to didanosine in patients with symptomatic HIV infection and disease progression. ddI Iberian Study Group.

D. Podzamczer, B. Clotet, J. Miro, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study

L. Lopalco, F. Lori, G. M. Ortiz, 2003, AIDS.

Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study

J. Romeu, Felipe García, A. Cruceta, 2000, AIDS.

[Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results].

Santiago Pérez-Hoyos, Santiago Moreno, Félix Gutiérrez, 2007, Enfermedades infecciosas y microbiologia clinica.

Long-Term CD4+ T-Cell Response to Highly Active Antiretroviral Therapy According to Baseline CD4+ T-Cell Count

Felipe García, G. Mestre, M. Plana, 2004, Journal of acquired immune deficiency syndromes.

Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults.

E. Negredo, J. Miro, J. Gatell, 2019, Enfermedades infecciosas y microbiologia clinica.

Pharmacokinetics and Pharmacodynamics of Low Dose Mycophenolate Mofetil in HIV-Infected Patients Treated with Abacavir, Efavirenz and Nelfinavir

Felipe García, M. Plana, T. Pumarola, 2005, Clinical pharmacokinetics.

[GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)].

J. Miro, M. Laguno, J. Vilardell, 2005, Enfermedades infecciosas y microbiologia clinica.

Effect of Mycophenolate Mofetil on Immune Response and Plasma and Lymphatic Tissue Viral Load During and After Interruption of Highly Active Antiretroviral Therapy for Patients With Chronic HIV Infection: A Randomized Pilot Study

Felipe García, M. Plana, M. Arnedo, 2004, Journal of Acquired Immune Deficiency Syndromes.

Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.

J. Miro, J. Gatell, C. Codina, 2008, AIDS research and human retroviruses.

The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

A. Mocroft, J. Miro, M. Cavassini, 2021, HIV medicine.

Genotypic and Phenotypic Resistance Patterns in Early-Stage HIV-1-Infected Patients Failing Initial Therapy with Stavudine, Didanosine and Nevirapine

Felipe García, G. Mestre, M. Plana, 2001, Antiviral therapy.

A Randomized Clinical Trial Comparing Nelfinavir Or Nevirapine Associated to Zidovudine/Lamivudine in HIV-Infected Naive Patients (The Combine Study)

D. Podzamczer, X. Badia, J. Miro, 2001, Antiviral therapy.

T-cell response to Toxoplasma gondii (Tg) antigens discriminates healthy individuals with and without c h ronic infection. Its interest to evaluate the reconstitution of Tg-specific CD4+ T cells in Tg- coinfected AIDS patients receiving antire t roviral therapy

M. Lejeune, Felipe García, M. Plana, 2001 .

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

D. Podzamczer, B. Clotet, J. Romeu, 1999, AIDS.

Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease

Felipe García, M. Plana, T. Gallart, 1998, The Lancet.

Incidence and Risk Factors for Mitochondrial Toxicity in Treated HIV/HCV-Coinfected Patients

Felipe García, J. Miro, J. Gatell, 2005, Antiviral therapy.

Barriers to health care services for migrants living with HIV in Spain

J. Miro, B. Ledergerber, E. Fernández, 2018, European journal of public health.

Mortality, Causes of Death and Associated Factors Relate to a Large HIV Population-Based Cohort

J. Miro, J. Gatell, J. Caylà, 2015, PloS one.

Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review

M. Plana, J. Miro, J. Gatell, 2015, Expert review of anti-infective therapy.

Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review.

J. Miro, F. Oppenheimer, A. Moreno, 2010, Transplantation Proceedings.

Enterococcal endocarditis revisited.

J. Miro, A. Moreno, F. Marco, 2015, Future microbiology.

Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database.

Bruno Hoen, Vance G Fowler, Didier Raoult, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity

M. Plana, J. Miro, J. Gatell, 2018, AIDS.

Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis

A. Cruceta, J. Miro, A. León, 2017, The Journal of antimicrobial chemotherapy.

Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort

J. Miro, A. Curran, A. Montoliu, 2019, HIV medicine.

Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009

J. Miro, J. Caylà, P. Domingo, 2011, AIDS research and therapy.

[2015 ESC Guidelines for the management of infective endocarditis].

J. Zamorano, J. Miro, B. Mulder, 2015, Kardiologia polska.

Community‐Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV‐Infected Adult Patients: A Matched Case‐Control Study

Felipe García, J. Miro, A. Torres, 2017, Chest.

Lack of evidence of a stable viral load set‐point in early stage asymptomatic patients with chronic HIV‐1 infection

B. Clotet, L. Ruiz, J. Romeu, 1998, AIDS.

Lymphocyte subpopulations in Spanish parenteral drug addicts.

T. Pumarola, T. Gallart, J. Miro, 1986, Scandinavian journal of infectious diseases.

Aetiology and prognostic factors of patients with AIDS presenting life-threatening acute respiratory failure.

R. Rodríguez-Roisín, J. Miro, J. Gatell, 1995, The European respiratory journal.

Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitis.

D. Podzamczer, M. Lejeune, Felipe García, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Gut microbiome signatures linked to HIV-1 reservoir size and viremia control

R. Paredes, B. Clotet, J. Martinez-Picado, 2021, bioRxiv.

Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up

T. Pumarola, J. Miro, J. Gatell, 2011, Journal of NeuroVirology.

Intracranial tuberculomas in patients with AIDS.

E. Tolosa, J. Miro, J. Mallolas, 1991, AIDS.

Pleural and peritoneal leishmaniasis in an AIDS patient

J. Miro, J. Gatell, F. Muñoz-Rodríguez, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era.

Felipe García, J. Miro, O. Sued, 2005, Journal of neurovirology.

Thrice-Weekly Sulfadiazine-Pyrimethamine for Maintenance Therapy of Toxoplasmic Encephalitis in HIV-Infected Patients

D. Podzamczer, A. Cruceta, J. Miro, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Henoch-Schönlein purpura complicating staphylococcal endocarditis in a heroin addict.

J. Miro, J. Montoliu, L. Revert, 1987, American journal of nephrology.

Overview of SARS-CoV-2 infection in adults living with HIV

Á. Soriano, J. Miro, J. Mallolas, 2021, The Lancet HIV.

[2015 ESC Guidelines for the management of infective endocarditis].

J. Zamorano, J. Miro, B. Mulder, 2015, Kardiologia polska.

Serum levels of β2-microglobulin, neopterin, TNF-α and soluble receptors of TNF-α and interleukin-2 in intravenous drug abusers according to HIV-1 status and stage of the HIV-1 infection

Felipe García, J. Miro, J. Gatell, 1998 .

Predictors of progression in chronically infected naive patients with plasma viraemia below 5000 copies/ml and CD4 T lymphocytes greater than 500 x 10(6)/I.

M. Plana, Á. Soriano, C. Vidal, 2001, AIDS.

Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection

Felipe García, M. Plana, Á. Soriano, 2000, AIDS.

Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states of HIV disease.

Felipe García, M. Plana, T. Gallart, 2000 .

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy.

M. Plana, C. Vidal, A. Cruceta, 1999, AIDS.

Non‐myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopenia

Antonio Martínez, Felipe García, J. Gatell, 2011, European journal of haematology.

Liver transplantation in HIV/hepatitis co-infection.

J. Miro, M. Laguno, J. García-Valdecasas, 2007, Journal of HIV therapy.

[Role of ceftaroline fosamil in the treatment of bacteremia and infectious endocarditis].

J. Miro, J. Pericàs, B. Almirante, 2014, Enfermedades infecciosas y microbiologia clinica.

Update on antiretroviral treatment during primary HIV infection

J. Miro, O. Sued, D. Nicolás, 2014, Expert review of anti-infective therapy.

Short-course antiretroviral therapy in primary HIV infection.

Steve Kaye, Kholoud Porter, Helen Rees, 2013, The New England journal of medicine.

Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.

C. Tural, T. Pumarola, J. Miro, 2011, Enfermedades infecciosas y microbiologia clinica.

The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels

J. Miro, D. Cooper, J. Weber, 2015, AIDS.

Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: support for the hypothesis of local virus replication.

B. Clotet, L. Ruiz, J. Romeu, 1999, AIDS.

Immunological and virological findings in a patient with exceptional post-treatment control: a case report.

R. Paredes, M. Plana, J. Miro, 2022, The lancet. HIV.

Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?

J. Miro, J. Rodríguez-Baño, Á. Pascual, 2014, Enfermedades infecciosas y microbiologia clinica.

Inflammatory Responses in Blood Samples of Human Immunodeficiency Virus-Infected Patients with Pulmonary Infections

Felipe García, T. Pumarola, J. Miro, 2004, Clinical Diagnostic Laboratory Immunology.

[Cardiac tamponade as the first manifestation of carcinoma of the esophagus].

J. Miro, M. Mateu, P. Navarro, 1992, Medicina clinica.

Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons

R. Chaisson, J. Miro, T. Sterling, 2016, AIDS.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Staphylococcal postoperative subannular left ventricular false aneurysm.

J. Miro, J. Pomar, C. Mestres, 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Residual low-level viral replication could explain discrepancies between viral load and CD4+ cell response in human immunodeficiency virus-infected patients receiving antiretroviral therapy.

M. Plana, C. Vidal, A. Cruceta, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical Characteristics and Outcome of Bloodstream Infections in HIV-Infected Patients with Cancer and Febrile Neutropenia: A Case–Control Study

J. Esteve, Felipe García, Á. Soriano, 2021, Infectious Diseases and Therapy.

Outcome and Prognostic Factors in HIV-1–Infected Patients on Dialysis in the cART Era: a GESIDA/SEN Cohort Study

J. Miro, A. Martínez‐Castelao, R. Jofré, 2011, Journal of acquired immune deficiency syndromes.

Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.

J. Miro, J. Gatell, J. Mallolas, 1993, AIDS.

Determinants of long-term survival in late HIV presenters: The prospective PISCIS cohort study

J. Miro, J. Casabona, I. Johansen, 2022, EClinicalMedicine.

Dialysis and Renal Transplantation in HIV-Infected Patients: a European Survey

A. Mocroft, O. Kirk, C. Katlama, 2010, Journal of acquired immune deficiency syndromes.

The EuroSIDA study: 25 years of scientific achievements

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2019, HIV medicine.

Recently acquired HIV infection in Spain (2003–2005): introduction of the serological testing algorithm for recent HIV seroconversion

C. Tural, T. Pumarola, J. Miro, 2008, Sexually Transmitted Infections.

Identifying high risk patients for Staphylococcus aureus infections: skin and soft tissue infections.

J. Miro, A. Trilla, 1995, Journal of chemotherapy.

Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation

J. Sterne, J. Miro, P. Reiss, 2018, Journal of the International AIDS Society.

Direct‐acting antivirals are effective and safe in HCV/HIV‐coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

J. Miro, V. Cuervas-Mons, M. Londoño, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Strategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review

D. Podzamczer, J. Miro, D. Giralt, 2021, BMC Public Health.

HTLV testing of solid organ transplant donors

J. Miro, E. Poveda, S. Sauleda, 2019, Clinical transplantation.

Tuberculosis in elderly patients in the city of Cali, Colombia: a hospital-based cohort study.

J. Miro, J. Caylà, L. Parra-Lara, 2020, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Structured Treatment Interruptions and Low Doses of IL-2 in Patients with Primary HIV Infection. Inflammatory, Virological and Immunological Outcomes

M. Plana, T. Pumarola, T. Gallart, 2015, PloS one.

Predictors of Tonsillar Tissue HIV-1 Viral Burden at Baseline and after 1 Year of Antiretroviral Therapy

Felipe García, G. Mestre, M. Plana, 2002, Antiviral therapy.

Lymphoid tissue viral burden and duration of viral suppression in plasma

Felipe García, M. Arnedo, C. Gil, 2001, AIDS.

Evaluation of the Roche COBAS® TaqMan® HIV-1 test for quantifying HIV-1 RNA in infected cells and lymphoid tissue.

Felipe García, C. Gil, T. Pumarola, 2011, Journal of virological methods.

Salvage Treatment with Cefiderocol Regimens in Two Intravascular Foreign Body Infections by MDR Gram-Negative Pathogens, Involving Non-Removable Devices

Á. Soriano, J. Miro, A. Moreno, 2021, Infectious Diseases and Therapy.

Behçet's disease in an HIV-1-infected patient treated with highly active antiretroviral therapy.

J. Miro, G. Espinosa, R. Cervera, 2006, The Israel Medical Association journal : IMAJ.

Cryopreserved homografts in the treatment of relapsing fungal cardiovascular infections.

J. Miro, J. Pomar, C. Mestres, 1994, The Journal of thoracic and cardiovascular surgery.

Hyperperfusion and early technetium-99m-HMPAO SPECT appearance of central nervous system toxoplasmosis.

J. Miro, A. Catafau, F. Lomeña, 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical Presentation of Individuals With Human T-Cell Leukemia Virus Type-1 Infection in Spain

J. Miro, E. Poveda, S. Sauleda, 2019, Open forum infectious diseases.

[Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: a case report].

J. Miro, V. Asensi, M. Tuset, 2011, Medicina clinica.

Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.

J. Miro, R. Belknap, J. Caylà, 2017, Annals of internal medicine.

Influence of environmental temperature on incidence of indinavir-related nephrolithiasis.

J. Miro, J. Gatell, J. Mallolas, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study.

J. Miro, A. Martínez‐Castelao, F. Cofán, 2008, AIDS research and human retroviruses.

Multicentre, randomised, open-label, phase IV–III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: study protocol for the SAFO trial

C. Tebé, J. Miro, S. Videla, 2021, BMJ Open.

Cyclosporine A in addition to standard ART during primary HIV-1 infection: pilot randomized clinical trial

M. Plana, T. Gallart, J. Miro, 2016, The Journal of antimicrobial chemotherapy.

Identification of recent HIV-1 infection among newly diagnosed cases in Catalonia, Spain (2006-08).

C. Tural, T. Pumarola, J. Miro, 2012, European journal of public health.

Evolution of resistance mutations pattern in HIV-1-infected patients during intensification therapy with a boosted protease inhibitor

Felipe García, M. Arnedo, T. Pumarola, 2005, AIDS.

Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature

J. Miro, J. Olalla, S. Grau, 2022, Expert review of anti-infective therapy.

Optimal Timing and Best Antiretroviral Regimen in Treatment-naive HIV-Infected Individuals with Advanced Disease

J. Miro, A. Antinori, F. Agüero, 2007, Journal of acquired immune deficiency syndromes.

Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.

D. Podzamczer, B. Clotet, J. Romeu, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Estimating the HIV undiagnosed population in Catalonia, Spain: descriptive and comparative data analysis to identify differences in MSM stratified by migrant and Spanish-born population

C. Tural, J. Miro, J. Caylà, 2018, BMJ Open.

[Clinical management of acute and chronic human immunodeficiency virus infection before starting antiretroviral treatment].

T. Pumarola, T. Gallart, J. Miro, 2011, Enfermedades infecciosas y microbiologia clinica.

Risk of selecting de novo drug-resistance mutations during structured treatment interruptions in patients with chronic HIV infection.

C. Gil, T. Pumarola, J. Miro, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Survival Outcomes and Effect of Early vs. Deferred cART Among HIV-Infected Patients Diagnosed at the Time of an AIDS-Defining Event: A Cohort Analysis

A. d’Arminio Monforte, C. Sabin, J. Miro, 2011, PloS one.

Evaluation of antiretroviral‐related errors and interventions by the clinical pharmacist in hospitalized HIV‐infected patients

J. Miro, C. Codina, J. Gatell, 2011, HIV medicine.

Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse.

J. Miro, F. Domínguez, P. García-Pavía, 2018, Journal of the American College of Cardiology.

Title: Pulmonary Infections in HIV-Infected Patients: An Update in the 21 Century

J. Miro, A. Torres, A. Moreno, 2011 .

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4+ T‐cell activation and dendritic cell maturation

N. Navaratnam, Felipe García, J. Gatell, 2016, Immunology and cell biology.

Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults.

Esteban Martínez, J. Miro, J. Gatell, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study

J. Miro, F. Domínguez, P. Muñoz, 2020, PloS one.

Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain.

T. Pumarola, J. Miro, J. Gatell, 2001 .

Comparación de tres métodos de cálculo de adherencia en pacientes con tratamiento antirretroviral

Felipe García, J. Miro, J. Mallolas, 2002 .

[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].

B. Clotet, J. Miro, J. Gatell, 2004, Enfermedades infecciosas y microbiologia clinica.

Noninvasive Diagnosis of Hepatic Fibrosis in HIV/HCV-Coinfected Patients

J. Miro, J. Gatell, A. León, 2007, Journal of acquired immune deficiency syndromes.

IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting.

J. Miro, A. Forner, M. Laguno, 2016, The Journal of antimicrobial chemotherapy.

Tuberculosis in recipients of solid-organ transplants during 1995-2015 in Cali, Colombia.

J. Miro, J. Caylà, J. García-Goez, 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine

Anne M Johnson, Andrew N. Phillips, Reggio Emilia, 1994 .

2016 Expert consensus document on prevention, diagnosis and treatment of short-term peripheral venous catheter-related infections in adult.

J. Miro, E. Bouza, P. Muñoz, 2016, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia.

Expert consensus document on prevention , diagnosis and treatment of short-term peripheral venous catheter-related infections in adults

J. Miro, E. Bouza, P. Muñoz, 2016 .

[Chondrocostal and chondrosternal tuberculosis in 2 heroin addicts infected with the human immunodeficiency virus].

J. Miro, J. Gatell, J. Mallolas, 1989, Medicina clinica.

Human Papillomavirus Infection in HIV-1 Infected Women in Catalonia (Spain): Implications for Prevention of Cervical Cancer

S. de Sanjosé, B. Lloveras, G. Sirera, 2012, PloS one.

Six-year experience with cryopreserved mitral homografts in the treatment of tricuspid valve endocarditis in HIV-infected drug addicts.

J. Miro, J. Pomar, C A Mestres, 1999, The Journal of heart valve disease.

[Kaposi's sarcoma associated with the acquired immunodeficiency syndrome. An analysis of 67 cases with a study of the prognostic factors].

J. Miro, J. Gatell, J. Mallolas, 1990, Medicina clinica.

Daptomycin compared to standard therapy for the treatment of native valve endocarditis.

J. Miro, V. Fowler, D. Levine, 2010, Enfermedades infecciosas y microbiologia clinica.

Optimizing outcomes in patients with serious Gram-positive infections.

J. Miro, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Immunoblot Profile as Predictor of Toxoplasmic Encephalitis in Patients Infected with Human Immunodeficiency Virus

J. Miro, B. Luft, P. Morlat, 2001, Clinical Diagnostic Laboratory Immunology.

Highly active antiretroviral therapy (HAART) modifies the incidence and outcome of visceral leishmaniasis in HIV-infected patients.

Felipe García, J. Miro, J. Gatell, 2002, Journal of acquired immune deficiency syndromes.

Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012)

T. Pumarola, J. Miro, J. Gatell, 2015, PloS one.

[Clinical-epidemiological characteristics and antiretroviral treatment trends in a cohort of HIV infected patients. The PISCIS Project].

D. Podzamczer, B. Clotet, C. Tural, 2005, Medicina clinica.

Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort.

D. Podzamczer, B. Clotet, C. Tural, 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[Heart transplantation in an HIV-1-infected patient with ischemic cardiomyopathy and severe pulmonary hypertension].

J. Miro, M. Castel, E. Roig, 2011, Revista espanola de cardiologia.

Heart transplantation in HIV-infected patients: more cases in Europe.

J. Miro, M. Castel, F. Pérez-Villa, 2011, The Journal of Heart and Lung Transplantation.

Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection

J. Miro, J. Gatell, E. Aznar, 1991, The Lancet.

The human immunodeficiency virus infection 40 years later

J. Miro, 2022, Medicina Clínica (English Edition).

Tacrolimus, Sirolimus and Everolimus Doses in HIV-Infected Solid-Organ Recipients, Requiring a Cobicistat-Based Antiretroviral Regimen: Report of Three Cases and Review

J. Miro, D. Redondo-Pachón, M. Crespo, 2021, Infectious Diseases and Therapy.

Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV‐positive individuals

Richard D Moore, J. Robins, M. Hernán, 2019, Statistics in medicine.

Cloxacillin-induced neutropenia.

J. Rello, J. Miro, J. Gatell, 1986, The Journal of infectious diseases.

Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.

D. Podzamczer, J. Martinez-Picado, J. Miro, 2021, Biochemical pharmacology.

Population-based assessment of SARS-CoV-2 infection among people living with HIV and the general population of Catalonia (March–December, 2020)

J. Miro, J. Casabona, R. Vivanco-Hidalgo, 2023, Enfermedades infecciosas y microbiologia clinica (English ed.).

Pregnancy in a Renal Transplant Recipient with HIV-1 Infection: A Case Report

J. Miro, J. Campistol, F. Oppenheimer, 2016, Antiviral therapy.

Long-term clinical follow-up, without antiretroviral therapy, of patients with chronic HIV-1 infection with good virological response to structured treatment interruption.

Felipe García, M. Plana, A. Cruceta, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Challenges in solid organ transplantation in people living with HIV

J. Miro, P. Grossi, C. Durand, 2019, Intensive Care Medicine.

Evaluation of an antibody avidity index method for detecting recent human immunodeficiency virus type 1 infection using an automated chemiluminescence immunoassay.

J. Miro, A. Montoliu, J. Casabona, 2015, Enfermedades infecciosas y microbiologia clinica.

Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

J. Miro, A. Forner, I. Bilbao, 2016, Hepatology.

Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients.

J. Miro, J. Campistol, F. Oppenheimer, 2007, AIDS research and human retroviruses.

Subacute cerebellar syndrome as the first manifestation of AIDS dementia complex

E. Tolosa, J. Miro, J. Mallolas, 1990, Acta neurologica Scandinavica.

Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma

V. Mazzaferro, J. Miro, A. Forner, 2020, JHEP reports : innovation in hepatology.

Rapid Communications: Failure of a Short‐Term Prednisone Regimen to Prevent Nevirapine‐Associated Rash: A Double‐Blind Placebo‐Controlled Trial: The GESIDA 09/99 Study

J. Miro, J. Blanco, A. Rivero, 2001, Journal of acquired immune deficiency syndromes.

Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study

Felipe García, J. Miro, A. Torres, 2017 .

Relevance of HIV-1-Specific CD4+ Helper T-Cell Responses During Structured Treatment Interruptions in Patients With CD4+ T-Cell Nadir Above 400/mm3

G. M. Ortiz, D. Nixon, C. Fagard, 2004, Journal of acquired immune deficiency syndromes.

[Adverse side effects of antiretroviral therapy: relationship between patients' perception and adherence].

J. Miro, J. Gatell, C. Codina, 2007, Medicina clinica.

Immunologic Reconstitution After 1 Year of Highly Active Antiretroviral Therapy, With or Without Protease Inhibitors

M. Lejeune, Felipe García, M. Plana, 2002, Journal of acquired immune deficiency syndromes.

Kaposi sarcoma-associated immune reconstitution inflammatory syndrome: in need of a specific case definition.

Denise Naniche, Mark Bower, J. Miro, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[The recommendations of GESIDA/SEFH/PNS for improving adherence to antiretroviral treatment. AIDS Study Group of the Spanish Society of Hospital Pharmacy and the National Plan on AIDS of the Minister of Health and Consumers].

J. Miro, A. Antela, P. Viciana, 2000, Enfermedades infecciosas y microbiologia clinica.

Consensus document for the treatment of bacteremia and endicarditis caused by methicillin-resistent Staphylococcus aureus.

J. Miro, E. Bouza, P. Tornos, 2009 .

[Reporting new HIV cases in Catalonia, Spain: is technical consensus feasible?].

J. Miro, J. Caylà, J. Casabona, 2003, Gaceta sanitaria.

Voriconazole and cobicistat-boosted antiretroviral salvage regimen co-administration to treat invasive aspergillosis in an HIV-infected patient.

J. Miro, J. Gatell, J. Blanco, 2016, The Journal of antimicrobial chemotherapy.

Transient Elastography for Predicting Liver-Related Events in CirrhoticHIV-Infected Patients

C. Tural, J. Miro, C. Quereda, 2017 .

Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome in a Rural Area of Mozambique

C. Menéndez, J. Miro, P. Alonso, 2011, PloS one.

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.

M. Hernán, J. Sterne, C. Sabin, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human immunodeficiency virus-infected patients?].

J. Miro, J. Pericàs, E. Letang, 2014, Enfermedades infecciosas y microbiologia clinica.

Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections

J. Miro, J. Mallolas, E. Martinez, 2022, AIDS.

Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands.

J. Miro, V. Falcó, J. Casabona, 2023, International journal of epidemiology.

A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.

D. Podzamczer, J. Miro, E. Martinez, 2001, The New England journal of medicine.

The model for end‐stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end‐stage liver disease: A prospective cohort study

J. Miro, J. Blanco, M. Laguno, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.

S. Meshnick, J. Miro, J. Gatell, 2008, Diagnostic microbiology and infectious disease.

Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis

Felipe García, J. Miro, J. Gatell, 2017, BMC Nephrology.

Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial

J. Miro, R. Belknap, J. Caylà, 2017 .

Treatment with integrase inhibitors alters SARS‐CoV‐2 neutralization levels measured with HIV‐based pseudotypes in people living with HIV

J. Miro, M. Buzón, J. Alcamí, 2023, Journal of medical virology.

Colorectal Adenomas.

J. Miro, J. Pericàs, J. Corredoira, 2016, New England Journal of Medicine.

Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease

R. Paredes, D. Podzamczer, B. Clotet, 2015, AIDS.

Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients.

B. Clotet, L. Ruiz, C. Vidal, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Clinical progression of severely immunosuppressed HIV-infected patients depends on virological and immunological improvement irrespective of baseline status.

D. Podzamczer, C. Tural, J. Miro, 2015, The Journal of antimicrobial chemotherapy.

Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients.

J. Miro, J. Gatell, C. Agustí, 2001, The European respiratory journal.

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients : a collaborative analysis of 18 HIV cohort studies

S. Cole, J. Sterne, R. Hogg, 2009 .

[2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)].

J. Zamorano, J. Miro, B. Mulder, 2016, Giornale italiano di cardiologia.

[Recommendations of the Spanish AIDS Study Group (GESIDA) and the National Aids Plan (PNS) for antiretroviral treatment in adult patients with human immunodeficiency virus infection in 2002].

J. Miro, J. Gatell, E. Martinez, 2002, Enfermedades infecciosas y microbiologia clinica.

[2015 ESC Guidelines for the management of infective endocarditis].

J. Zamorano, J. Miro, B. Mulder, 2015, Kardiologia polska.

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

M. Hernán, D. Podzamczer, A. Winston, 2014, Neurology.

[Disseminated cryptococcosis in patients with AIDS. Prognostic factors of poor outcome].

Á. Soriano, J. Miro, J. Gatell, 1999, Medicina clinica.

[Analysis of the duration of and reasons for changing the first combination of antiretroviral therapy].

J. Miro, J. Gatell, C. Codina, 2010, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

PATIENTS AND METHODS

J. Miro, G. Quaglio, O. Sued, 1978 .

[HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)].

C. Tural, J. Miro, M. Salavert, 2009, Enfermedades Infecciosas y Microbiologia Clinica.

Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections

E. Álava, J. Miro, E. de Álava, 2023, Frontiers in medicine.

Mandell GL, Bennett JE, Dolin R. Principles and Practice of Infectious Diseases (PPID). Séptima Edición. Volúmenes 1 y 2. Philadelphia, PA. Churchill Livingston: Elsevier; 2010. p. 4028. ISBN 978-0-443-06839-3

J. Miro, 2010 .

Are HIV-infected donors suitable for renal transplantation?

J. Miro, F. Oppenheimer, J. Campistol, 2011, Transplantation.

Community-Acquired Legionella Pneumonia in Human Immunodeficiency Virus–Infected Adult Patients: A Matched Case-Control Study

Felipe García, J. Miro, A. Torres, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[In vitro effect of heroin on neutrophil polymorphonuclear leukocytes from peripheral blood].

J. Miro, J. Gatell, E. Feliú, 1996, Medicina clinica.

Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).

Felipe García, M. Plana, M. Arnedo, 2006, Enfermedades Infecciosas y Microbiologia Clinica.

Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.

J. Miro, R. Belknap, J. Caylà, 2017, Annals of internal medicine.

Dialysis and Renal Transplantation in HIV-Infected Patients: a European Survey

A. Mocroft, O. Kirk, C. Katlama, 2010, Journal of acquired immune deficiency syndromes.

Outcome and Prognostic Factors in HIV-1–Infected Patients on Dialysis in the cART Era: a GESIDA/SEN Cohort Study

J. Miro, R. Jofré, F. Cofán, 2011, Journal of acquired immune deficiency syndromes.

Renal transplantation in HIV-infected patients: 2010 update.

J. Miro, F. Oppenheimer, J. Campistol, 2011, Kidney International.

[Prevalence of HIV-1-infection in dialysis units in Spain and potential candidates for renal transplantation: results of a Spanish survey].

J. A. Oliver, J. Miro, R. Jofré, 2005, Enfermedades infecciosas y microbiologia clinica.

[Spanish GESIDA/Nacional AIDS Plan Recommendations for antiretroviral therapy in HIV-infected Adults (October 2004)].

B. Clotet, J. Miro, J. Gatell, 2004 .

Cardiac surgery in human immunodeficiency virus positive patients

J. Miro, C. Mestres, 2006 .

Human immunodeficiency virus infection and the kidney.

J. Miro, L. Revert, J. Almirall, 1992, Nephron.

Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.

B. Clotet, J. Romeu, A. Cruceta, 2000, Journal of acquired immune deficiency syndromes.

Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4+ T‐cell activation and dendritic cell maturation

N. Navaratnam, Felipe García, J. Gatell, 2016, Immunology and cell biology.

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018).

D. Podzamczer, E. Negredo, J. Miro, 2019, Enfermedades infecciosas y microbiologia clinica.

Reply to Cuervo et al.

Á. Chamorro, J. Miro, A. Moreno, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

2015 ESC Guidelines for the management of infective endocarditis.

J. Zamorano, J. Miro, B. Mulder, 2016, Revista española de cardiología.

Consensus document on the management of renal disease in HIV-infected patients.

E. Negredo, J. Miro, E. Martinez, 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Failure of a short-term prednisone regimen to prevent nevirapine-associated rash: a double-blind placebo-controlled trial: the GESIDA 09/99 study.

J. Miro, J. Blanco, A. Rivero, 2001, Journal of acquired immune deficiency syndromes.

Liver Retransplantation in Patients With HIV‐1 Infection: An International Multicenter Cohort Study

J. Miro, P. Stock, S. Nishida, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Relationship among Streptococcus gallolyticus Subsp. gallolyticus, Enterococcus faecalis and Colorectal Neoplasms in Recurrent Endocarditis: A Historical Case Series

J. Miro, J. Llach, L. Moreira, 2022, Journal of clinical medicine.

Phylogenetic Analysis of Viridans Group Streptococci Causing Endocarditis

C. Woods, J. Miro, D. Murdoch, 2008, Journal of Clinical Microbiology.

Perception of quality of care using patient reported experience measures (PREMs) in a cohort of adults with HIV: A cross-sectional study

J. Miro, E. Fernández, J. Mallolas, 2022, Medicine.

Daptomycin: the role of high-dose and combination therapy for Gram-positive infections.

J. Miro, I. Gould, M. Rybak, 2013, International journal of antimicrobial agents.

Comparison of T‐Cell Subsets' Reconstitution After 12 Months of Highly Active Antiretroviral Therapy Initiated During Early Versus Advanced States of HIV Disease

J. Gatell, M. Plana, T. Gallart, 2000, Journal of acquired immune deficiency syndromes.

[Role of ceftaroline fosamil in the treatment of bacteremia and infectious endocarditis].

J. Miro, J. Pericàs, B. Almirante, 2014, Enfermedades infecciosas y microbiologia clinica.

Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia

J. Miro, J. Gatell, J. Mallolas, 1991, The Lancet.